ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2020–2021
Source type
Book Series
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Anti-Obesity Drug Discovery and Development
Anti-Obesity Drug Discovery and Development is not currently indexed in Scopus. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 2210-2698Verify ISSN ↗2467-9615Verify ISSN ↗
Publisher: Bentham Science Publishers
Scopus · Inactive
0
Indexed in
Cost to publish: No APC data — check the publisher
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Anti-Obesity Drug Discovery and Development indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2020–2021).
What is the impact factor of Anti-Obesity Drug Discovery and Development?
Anti-Obesity Drug Discovery and Development has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Anti-Obesity Drug Discovery and Development and what is its ISSN?
Anti-Obesity Drug Discovery and Development is published by Bentham Science Publishers. Its print ISSN is 2210-2698 and its online ISSN is 2467-9615.
Is Anti-Obesity Drug Discovery and Development in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Anti-Obesity Drug Discovery and Development open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Anti-Obesity Drug Discovery and Development for 2 years, between 2020 and 2021. Coverage ended in 2021, 5 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 20 works and 6 citations for the title. Its most recent paper is from 2021, in line with the end of Scopus coverage in 2021, which suggests the journal stopped publishing around then.
How well cited is Anti-Obesity Drug Discovery and Development? — open metrics via OpenAlex
Anti-Obesity Drug Discovery and Development has an h-index of 1 and a 2-year mean of 0 citations per paper (OpenAlex).
1
h-index
0
2-yr mean citations
0
i10-index
20
works indexed
6
total citations
Anti-Obesity Drug Discovery and Development published 8 papers in 2021; its busiest recent year was 2018 with 10. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Anti-Obesity Drug Discovery and Development? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2021. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2021
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Bentham Science Publishers
Bentham Science Publishers has 239 other titles in our data; 119 are currently indexed in Scopus.
Journal Scopus status
Adolescent Psychiatry Active Anti-Cancer Agents in Medicinal Chemistry Active Anti-Infective Agents Active Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry Active Cardiovascular and Hematological Disorders - Drug Targets Active Central Nervous System Agents in Medicinal Chemistry Active Related journals
8 journals Journal Indexed in
Applications of NMR Spectroscopy Not in these indexes Cardiovascular and Hematological Disorders - Drug Targets Scopus Q3 Central Nervous System Agents in Medicinal Chemistry Scopus Q3 Clinical Cancer Drugs Not in these indexes Clinical Immunology, Endocrine and Metabolic Drugs Not in these indexes Clinical Practice and Epidemiology in Mental Health Scopus Q2 CNS and Neurological Disorders - Drug Targets Scopus Q1 WoS SCIE Combinatorial Chemistry and High Throughput Screening Scopus Q2 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.